BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 18025202)

  • 1. The rheumatoid arthritis-associated autoantigen hnRNP-A2 (RA33) is a major stimulator of autoimmunity in rats with pristane-induced arthritis.
    Hoffmann MH; Tuncel J; Skriner K; Tohidast-Akrad M; Türk B; Pinol-Roma S; Serre G; Schett G; Smolen JS; Holmdahl R; Steiner G
    J Immunol; 2007 Dec; 179(11):7568-76. PubMed ID: 18025202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant expression of the autoantigen heterogeneous nuclear ribonucleoprotein-A2 (RA33) and spontaneous formation of rheumatoid arthritis-associated anti-RA33 autoantibodies in TNF-alpha transgenic mice.
    Hayer S; Tohidast-Akrad M; Haralambous S; Jahn-Schmid B; Skriner K; Trembleau S; Dumortier H; Pinol-Roma S; Redlich K; Schett G; Muller S; Kollias G; Smolen J; Steiner G
    J Immunol; 2005 Dec; 175(12):8327-36. PubMed ID: 16339574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immmunopathogenesis of rheumatoid arthritis; induction of arthritogenic autoimmune responses by proinflammatory stimuli.
    Hoffmann M; Hayer S; Steiner G
    Ann N Y Acad Sci; 2009 Sep; 1173():391-400. PubMed ID: 19758178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of anti-RA33 hnRNP autoantibodies and transient spread to U1-A snRNP complex of spliceosome by idiotypic manipulation with anti-RA33 antibody preparation in mice.
    Steiner G; Shovman O; Skriner K; Gilburd B; Langevitz P; Miholits M; Hoet R; Levy Y; Zandman-Goddard G; Hoefler E; Smolen JS; Shoenfeld Y
    Clin Exp Rheumatol; 2002; 20(4):517-24. PubMed ID: 12180437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to native and citrullinated RA33 (hnRNP A2/B1) challenge citrullination as the inciting principle underlying loss of tolerance in rheumatoid arthritis.
    Konig MF; Giles JT; Nigrovic PA; Andrade F
    Ann Rheum Dis; 2016 Nov; 75(11):2022-2028. PubMed ID: 26865600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of autoreactive T cells to the autoantigens heterogeneous nuclear ribonucleoprotein A2 (RA33) and filaggrin in patients with rheumatoid arthritis.
    Fritsch R; Eselböck D; Skriner K; Jahn-Schmid B; Scheinecker C; Bohle B; Tohidast-Akrad M; Hayer S; Neumüller J; Pinol-Roma S; Smolen JS; Steiner G
    J Immunol; 2002 Jul; 169(2):1068-76. PubMed ID: 12097415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunodominant T-cell epitopes of hnRNP-A2 associated with disease activity in patients with rheumatoid arthritis.
    Trembleau S; Hoffmann M; Meyer B; Nell V; Radner H; Zauner W; Hammer J; Aichinger G; Fischer G; Smolen J; Steiner G
    Eur J Immunol; 2010 Jun; 40(6):1795-808. PubMed ID: 20232340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Inflammation and Bone Erosion by RNA Interference-Mediated Silencing of Heterogeneous Nuclear RNP A2/B1 in Two Experimental Models of Rheumatoid Arthritis.
    Herman S; Fischer A; Presumey J; Hoffmann M; Koenders MI; Escriou V; Apparailly F; Steiner G
    Arthritis Rheumatol; 2015 Sep; 67(9):2536-46. PubMed ID: 26017221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune reactivity to connective tissue antigens in pristane induced arthritis.
    Morgan R; Wu B; Song Z; Wooley PH
    J Rheumatol; 2004 Aug; 31(8):1497-505. PubMed ID: 15290727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune response to the spliceosome. An immunologic link between rheumatoid arthritis, mixed connective tissue disease, and systemic lupus erythematosus.
    Hassfeld W; Steiner G; Studnicka-Benke A; Skriner K; Graninger W; Fischer I; Smolen JS
    Arthritis Rheum; 1995 Jun; 38(6):777-85. PubMed ID: 7779120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The concurrence of rheumatoid arthritis and limited systemic sclerosis: clinical and serologic characteristics of an overlap syndrome.
    Zimmermann C; Steiner G; Skriner K; Hassfeld W; Petera P; Smolen JS
    Arthritis Rheum; 1998 Nov; 41(11):1938-45. PubMed ID: 9811047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and partial sequencing of the nuclear autoantigen RA33 shows that it is indistinguishable from the A2 protein of the heterogeneous nuclear ribonucleoprotein complex.
    Steiner G; Hartmuth K; Skriner K; Maurer-Fogy I; Sinski A; Thalmann E; Hassfeld W; Barta A; Smolen JS
    J Clin Invest; 1992 Sep; 90(3):1061-6. PubMed ID: 1522214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The spliceosomal autoantigen heterogeneous nuclear ribonucleoprotein A2 (hnRNP-A2) is a major T cell autoantigen in patients with systemic lupus erythematosus.
    Fritsch-Stork R; Müllegger D; Skriner K; Jahn-Schmid B; Smolen JS; Steiner G
    Arthritis Res Ther; 2006; 8(4):R118. PubMed ID: 16859514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleic acid-stimulated antigen-presenting cells trigger T cells to induce disease in a rat transfer model of inflammatory arthritis.
    Hoffmann MH; Skriner K; Herman S; Baumann C; Steiner CW; Ospelt C; Meyer B; Gleiss A; Pfatschbacher J; Niederreiter B; Tuncel J; Zanoni G; Steiner G
    J Autoimmun; 2011 May; 36(3-4):288-300. PubMed ID: 21439786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-RA33 autoantibodies may recognize epitopes in the N-terminal region of hnRNP-A2 (RA33).
    Skriner K; Steiner G; Sommergruber WH; Sinski A; Smolen JS
    Clin Exp Rheumatol; 1994; 12 Suppl 11():S79-82. PubMed ID: 7539351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-A2/RA33 autoantibodies are directed to the RNA binding region of the A2 protein of the heterogeneous nuclear ribonucleoprotein complex. Differential epitope recognition in rheumatoid arthritis, systemic lupus erythematosus, and mixed connective tissue disease.
    Skriner K; Sommergruber WH; Tremmel V; Fischer I; Barta A; Smolen JS; Steiner G
    J Clin Invest; 1997 Jul; 100(1):127-35. PubMed ID: 9202064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and immunological aspects of autoantibodies to RA33/hnRNP-A/B proteins--a link between RA, SLE and MCTD.
    Steiner G; Skriner K; Hassfeld W; Smolen JS
    Mol Biol Rep; 1996; 23(3-4):167-71. PubMed ID: 9112225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B- and T-cell autoantigens in pristane-induced arthritis.
    Barker RN; Easterfield AJ; Allen RF; Wells AD; Elson CJ; Thompson SJ
    Immunology; 1996 Oct; 89(2):189-94. PubMed ID: 8943713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of pristane-induced arthritis, a murine model of chronic disease: response to antirheumatic agents, expression of joint cytokines, and immunopathology.
    Patten C; Bush K; Rioja I; Morgan R; Wooley P; Trill J; Life P
    Arthritis Rheum; 2004 Oct; 50(10):3334-45. PubMed ID: 15476226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple specificities of autoantibodies against hnRNP A/B proteins in systemic rheumatic diseases and hnRNP L as an associated novel autoantigen.
    Siapka S; Patrinou-Georgoula M; Vlachoyiannopoulos PG; Guialis A
    Autoimmunity; 2007 May; 40(3):223-33. PubMed ID: 17453722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.